You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
國藥現代(600420.SH):注射用阿莫西林鈉克拉維酸鉀通過仿製藥質量和療效一致性評價
格隆匯 04-17 16:10

格隆匯4月17日丨國藥現代(600420.SH)公佈,公司全資子公司國藥集團威奇達藥業有限公司(簡稱國藥威奇達)收到國家藥品監督管理局核准簽發的《藥品補充申請批准通知書》,批准注射用阿莫西林鈉克拉維酸鉀(0.6g、1.2g)通過仿製藥質量和療效一致性評價。

阿莫西林鈉克拉維酸鉀為阿莫西林鈉和克拉維酸鉀的複方製劑,主要用於敏感菌引起的各種感染,如嚴重的耳鼻喉感染,慢性支氣管炎急性加重,社區獲得性肺炎,膀胱炎,腎盂腎炎,皮膚和軟組織感染,骨和關節感染,腹腔內感染和女性生殖器感染等。也可用於預防與成人主要外科手術相關的感染,如胃腸道、盆腔、頭部和頸部、膽道手術等。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account